Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) Sets New 1-Year High – Should You Buy?

Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) shares hit a new 52-week high during trading on Wednesday . The stock traded as high as $10.42 and last traded at $10.15, with a volume of 33930 shares traded. The stock had previously closed at $9.69.

Analyst Ratings Changes

Separately, Deutsche Bank Aktiengesellschaft restated a “buy” rating on shares of Fresenius SE & Co. KGaA in a research report on Monday, February 3rd.

Fresenius SE & Co. KGaA Price Performance

The stock has a 50 day moving average price of $9.31 and a two-hundred day moving average price of $9.18. The company has a quick ratio of 1.05, a current ratio of 1.36 and a debt-to-equity ratio of 0.57.

Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) last posted its quarterly earnings data on Wednesday, February 26th. The company reported $0.18 earnings per share for the quarter. Equities analysts anticipate that Fresenius SE & Co. KGaA will post 0.79 earnings per share for the current year.

Fresenius SE & Co. KGaA Company Profile

Fresenius SE & Co KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure.